ADC Therapeutics SA (NYSE:ADCT) Q3 2022 Earnings Call Transcript November 8, 2022
ADC Therapeutics SA misses on earnings expectations. Reported EPS is $-0.65 EPS, expectations were $-0.35.
Operator: Welcome to the ADC Therapeutics Third Quarter 2022 Financial Results Conference Call. My name is Kevin, and I’ll be your operator for today’s call. At this time, all participants are in listen-only mode. Later we will conduct a question-and-answer session. I will now turn the call over to Amanda...
